Viewing Study NCT05329194

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-03-01 @ 12:05 PM
Study NCT ID: NCT05329194
Status: COMPLETED
Last Update Posted: 2025-10-14
First Post: 2022-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Inhaled corticosteroids (ICS) View
None Post-Authorization View
None Baseline Blood eosinophil count (BEC) View
None long-acting- β2 Agonist (LABA) View
None Real-world participant population View